These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2576198)

  • 1. [Transdermal treatment using the betablocker mepindolol].
    Arzneimittelforschung; 1989 Nov; 39(11A):1487-517. PubMed ID: 2576198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Human pharmacologic studies on transdermal administration of mepindolol. Pharmacodynamic and orienting pharmacokinetics].
    Liedtke RK; Chen LS; Mangold B; Haase W
    Arzneimittelforschung; 1989 Nov; 39(11A):1501-4. PubMed ID: 2576199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacodynamic effects of the beta-blocker mepindolol administered transdermally to healthy volunteers].
    Liedtke RK
    Schweiz Rundsch Med Prax; 1987 Jul; 76(30-31):854-6. PubMed ID: 2889251
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of mepindolol and propranolol in normal man. 1st communication: study design, clinical and pharmacodynamic aspects.
    de Mey C; Enterling D; Ederhof M; Wesche H; Osterwald H
    Arzneimittelforschung; 1989 Nov; 39(11A):1505-8. PubMed ID: 2576200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-ischemic action of the transdermally applied beta-receptor blocker, mepindolol in patients with stable angina pectoris].
    Bonelli J; Gazo F; Liedtke RK
    Arzneimittelforschung; 1989 Nov; 39(11A):1515-7. PubMed ID: 2576203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of mepindolol and propranolol in normal man. 2nd communication: pharmacokinetic and neuro-endocrine aspects.
    de Mey C; Meineke I; Enterling D; Rehbock C; Osterwald H
    Arzneimittelforschung; 1989 Nov; 39(11A):1508-12. PubMed ID: 2576201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of mepindolol sulphate.
    Bonelli J; Hitzenberger G; Krause W; Wendt H; Speck U
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):169-76. PubMed ID: 6103882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal beta-blocker therapy in essential hypertension.
    Spieker C; Vetter H; Liedtke R; Zidek W; Vetter W
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):199S-200S. PubMed ID: 2901265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocking potency of mepindolol and pindolol against isoproterenol-induced inotropic and chronotropic responses in guinea pig atria.
    Anderson WG
    J Cardiovasc Pharmacol; 1984; 6(1):7-11. PubMed ID: 6199615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of mepindolol in plasma after transdermal drug delivery by high-performance liquid chromatography with electrochemical detection.
    Meineke I; Hartnack S; De Mey C
    J Chromatogr; 1990 Mar; 526(1):240-5. PubMed ID: 2341539
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of a new transdermal delivery system for bopindolol.
    Drewe J; Meier R; Timonen U; Thumshirn M; Munzer J; Kissel T; Gyr K
    Br J Clin Pharmacol; 1991 Jun; 31(6):671-6. PubMed ID: 1678271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transdermal beta blockers: effect on 24-hour blood pressure profile in hypertensive patients].
    Spieker C; Vetter W; Hany S; Liedke R; Vetter H
    Schweiz Rundsch Med Prax; 1987 Apr; 76(17):467-8. PubMed ID: 3602765
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphate.
    Krause W; Schwartzkopff W
    Arzneimittelforschung; 1983; 33(9):1306-7. PubMed ID: 6685513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mepindolol reduction of the degradation of phospholipids and the necrosis induced by myocardial ischemia].
    Ambrosio G; Cappelli Bigazzi M; Perrone Filardi P; Pellegrino A; Vallone C; Chiariello M
    G Ital Cardiol; 1985 Feb; 15(2):224-31. PubMed ID: 2861135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of mepindolol sulphate in animals.
    Krause W; Kühne G; Täuber U
    Eur J Drug Metab Pharmacokinet; 1980; 5(4):241-7. PubMed ID: 6113960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
    Reiterer W
    Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy.
    Bakish D; Hooper CL; Thornton MD; Wiens A; Miller CA; Thibaudeau CA
    Int Clin Psychopharmacol; 1997 Mar; 12(2):91-7. PubMed ID: 9219044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of polyethylene glycol in the adhesive layer of two-layer transdermal plasters on the liberation of a beta blocker].
    Dittgen M; Adam H
    Pharmazie; 1991 Mar; 46(3):223-4. PubMed ID: 1679240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.